ANVS Latest Press Releases

-- October 30, 2026 --

Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE Globe Newswire 5:00 PM

-- October 29, 2026 --

Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 Globe Newswire 8:00 AM

-- October 22, 2026 --

Annovis to Attend the CTAD 2026 with Three Presentations Globe Newswire 8:00 AM

-- September 23, 2026 --

Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's Disease Globe Newswire 8:00 AM

-- August 25, 2026 --

Annovis to Host Corporate Update Webinar on September 2, 2026 Globe Newswire 8:00 AM

-- August 14, 2026 --

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results Globe Newswire 8:00 AM

-- July 7, 2026 --

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer's Disease Globe Newswire 7:00 AM

-- July 1, 2026 --

Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes